Tumor immune tissue response to a solitary fibrous tumor treated with pazopanib. Issue 6 (17th June 2021)

• Record Type: Journal Article
• Authors: Kawano, Toshiaki; Hirano, Takashi; Fujinaga, Maki; Kadowaki, Yoshinori; Matsunaga, Takayuki; Tateyama, Kaori; Kizu, Yumi; Suzuki, Masashi
• Is Part Of: Clinical case reports. Volume 9:Issue 6(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-06-17
• Subjects: immunohistochemistry -- pazopanib -- solitary fibrous tumor -- vascular endothelial growth factor; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.4056
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: In our case, tumor tissues were collected thrice during the course of treatment for immunohistological evaluation. The tumor was consistently positive for VEGF, suggesting that pazopanib was effective in the treatment of solitary fibrous tumor. Abstract : In our case, tumor tissues were collected thrice during the course of treatment for immunohistological evaluation. The tumor was consistently positive for VEGF, suggesting that pazopanib was effective in the treatment of solitary fibrous tumor.